Bulletin
Investor Alert

Dow Jones Newswires Archives | Email alerts

Dec. 9, 2019, 4:09 a.m. EST

Roche extends tender offer for Spark Therapeutics

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Roche Holding AG (ROG)
  • X
    Spark Therapeutics Inc. (ONCE)

or Cancel Already have a watchlist? Log In

By Kim Richters


Spark Therapeutics

Roche Holding AG said Monday that it has extended the offer period for its planned takeover of biotechnology company Spark Therapeutics Inc. to Dec. 16.

Roche said the offer was extended to provide additional time for the U.S. Federal Trade Commission and the U.K. Competition and Markets Authority to complete their reviews of the pending acquisition.

The period for Roche’s /zigman2/quotes/206324342/delayed CH:ROG -0.24% offer of $114.50 per share has been extended several times and was set to expire on Dec. 10.

As of Dec. 6, around 14.9% of Spark’s /zigman2/quotes/200464619/composite ONCE +2.55%  outstanding shares had been tendered, according to Roche.

/zigman2/quotes/206324342/delayed
CH : Switzerland: SWX
CHF 312.90
-0.75 -0.24%
Volume: 1.61M
Aug. 11, 2020 5:31p
P/E Ratio
20.91
Dividend Yield
2.88%
Market Cap
CHF268.18 billion
Rev. per Employee
CHF601,914
loading...
/zigman2/quotes/200464619/composite
US : U.S.: Nasdaq
$ 113.57
+2.82 +2.55%
Volume: 0.00
Dec. 16, 2019 5:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
N/A
Rev. per Employee
$175,883
loading...

Get news alerts on Spark Therapeutics Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

World News from MarketWatch

Link to MarketWatch's Slice.